AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G] REGENXBIO Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



BlackRock Portfolio Management LLC
Signature:Spencer Fleming
Name/Title:Managing Director
Date:07/15/2025
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

Regenxbio

NASDAQ:RGNX

RGNX Rankings

RGNX Latest News

RGNX Latest SEC Filings

RGNX Stock Data

407.65M
46.62M
7.66%
87.45%
10.86%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
ROCKVILLE